{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:12:43Z","timestamp":1773850363026,"version":"3.50.1"},"reference-count":23,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"FCT (Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia, I.P.)","doi-asserted-by":"publisher","award":["2022.01788.PTDC"],"award-info":[{"award-number":["2022.01788.PTDC"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Inherited metabolic disorders (IMDs), commonly referred to as inborn errors of metabolism, represent a spectrum of disorders with a defined (or presumed) primary genetic cause which disrupts the normal metabolism of essential molecules in the body [...]<\/jats:p>","DOI":"10.3390\/biomedicines12010174","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T11:43:53Z","timestamp":1705059833000},"page":"174","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Inherited Metabolic Disorders: From Bench to Bedside"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6919-1072","authenticated-orcid":false,"given":"Tiago","family":"Fonseca","sequence":"first","affiliation":[{"name":"Faculdade de Medicina, Universidade de Coimbra, 3000-548 Coimbra, Portugal"},{"name":"CAGE, Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade (i3S), University of Porto, 4200-135 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2252-6105","authenticated-orcid":false,"given":"M. F\u00e1tima","family":"Macedo","sequence":"additional","affiliation":[{"name":"CAGE, Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade (i3S), University of Porto, 4200-135 Porto, Portugal"},{"name":"Departamento de Ci\u00eancias M\u00e9dicas, University of Aveiro, 3810-193 Aveiro, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jimd.12348","article-title":"An International Classification of Inherited Metabolic Disorders (ICIMD)","volume":"44","author":"Ferreira","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/adc.2005.091637","article-title":"The incidence of inherited metabolic disorders in the West Midlands, UK","volume":"91","author":"Sanderson","year":"2006","journal-title":"Arch. Dis. Child."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Amaral, O., Martins, M., Oliveira, A.R., Duarte, A.J., Mondrag\u00e3o-Rodrigues, I., and Macedo, M.F. (2023). The Biology of Lysosomes: From Order to Disorder. Biomedicines, 11.","DOI":"10.3390\/biomedicines11010213"},{"key":"ref_4","first-page":"1","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Coutinho, M.F., Lacerda, L., and Alves, S. (2012). Glycosaminoglycan storage disorders: A review. Biochem. Res. Int.","DOI":"10.1155\/2012\/471325"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lopes, N., Maia, M.L., Pereira, C.S., Mondrag\u00e3o-Rodrigues, I., Martins, E., Ribeiro, R., Gaspar, A., Aguiar, P., Garcia, P., and Cardoso, M.T. (2023). Leukocyte Imbalances in Mucopolysaccharidoses Patients. Biomedicines, 11.","DOI":"10.20944\/preprints202305.2104.v1"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1084\/jem.20060921","article-title":"Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases","volume":"203","author":"Gadola","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/eji.200737160","article-title":"Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism","volume":"37","author":"Facciotti","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4049\/jimmunol.177.1.26","article-title":"Cutting edge: Impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein","volume":"177","author":"Sagiv","year":"2006","journal-title":"J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ymgme.2012.02.014","article-title":"Enzyme replacement therapy partially prevents invariant Natural Killer T cell deficiency in the Fabry disease mouse model","volume":"106","author":"Macedo","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.20061562","article-title":"The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells","volume":"204","author":"Schrantz","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pereira, C.S., Ribeiro, H., and Macedo, M.F. (2017). From lysosomal storage diseases to NKT cell activation and back. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18030502"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41590-019-0504-0","article-title":"Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin","volume":"20","author":"Melum","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zedde, M., Pascarella, R., Cavallieri, F., Pezzella, F.R., Grisanti, S., Di Fonzo, A., and Valzania, F. (2022). Anderson\u2013Fabry Disease: A New Piece of the Lysosomal Puzzle in Parkinson Disease?. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123132"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-5960-2-20","article-title":"Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice","volume":"2","author":"Nelson","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.nbd.2017.11.006","article-title":"The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson\u2019s disease brain in association with the pathologic accumulation of alpha-synuclein","volume":"110","author":"Nelson","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jns.2008.04.011","article-title":"Decreased activities of lysosomal acid alpha-d-galactosidase A in the leukocytes of sporadic Parkinson\u2019s disease","volume":"271","author":"Wu","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1212\/WNL.0000000000001450","article-title":"Clinical prodromes of neurodegeneration in Anderson-Fabry disease","volume":"84","author":"Hughes","year":"2015","journal-title":"Neurology"},{"key":"ref_20","first-page":"1003","article-title":"An autopsied case of Fabry\u2019s disease presenting with parkinsonism and cardiomegaly as a cardinal clinical manifestation","volume":"34","author":"Orimo","year":"1994","journal-title":"Rinsho Shinkeigaku"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mds.20675","article-title":"Parkinsonism and Anderson Fabry\u2019s disease: A case report","volume":"21","author":"Buechner","year":"2006","journal-title":"Mov. Disord."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kodr\u00edkov\u00e1, R., Pakanov\u00e1, Z., Krch\u0148\u00e1k, M., \u0160ediv\u00e1, M., \u0160est\u00e1k, S., Kv\u011bto\u0148, F., Beke, G., \u0160alingov\u00e1, A., Skalick\u00e1, K., and Brennerova, K. (2023). N-Glycoprofiling of SLC35A2-CDG: Patient with a Novel Hemizygous Variant. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020580"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Wilke, M.V.M.B., de Oliveira, B.M., Starosta, R.T., Shinawi, M., Lu, L., He, M., Ma, Y., Stoll, J., de Souza, C.F.M., and de Siqueira, A.C.M. (2023). A Broad Characterization of Glycogen Storage Disease IV Patients: A Clinical, Genetic, and Histopathological Study. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020363"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/1\/174\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:45:55Z","timestamp":1760103955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/1\/174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["biomedicines12010174"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines12010174","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]}}}